DORZAM PLUS

This brand name is authorized in Ecuador

Active ingredients

The drug DORZAM PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1 Desonide
UNII J280872D1O - DESONIDE

Desonide is a low-potency topical corticosteroid. Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in the treatment of atopic dermatitis is unknown.

Read about Desonide
2 Nystatin
UNII BDF1O1C72E - NYSTATIN

Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans.

Read about Nystatin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D07XC Corticosteroids, potent, other combinations D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations
Discover more medicines within D07XC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria Identifier(s): 2562-MEN-0120

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.